Metraipolis › archive › dc_d2e5b969ded8

Celastrol increases anoikis sensitivity to suppress triple-negative breast cancer via EGFR pathway and p-EMT state regulation — Europe PMC PMID:41847133

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41847133
DOI
10.3389/fphar.2026.1747871
License (as archived)
solo-consultazione
Archived
2026-11-05T09:52:50.246Z
SHA-256 of the archived text
bdeac72c77973506401a340ed330b8bed4451300cfcd784289662022607012e1
Stable URL of this page
https://metraipolis.com/documento/dc_d2e5b969ded8

How to cite

Celastrol increases anoikis sensitivity to suppress triple-negative breast cancer via EGFR pathway and p-EMT state regulation — Europe PMC PMID:41847133 — Europe PMC (en), https://europepmc.org/article/MED/41847133 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d2e5b969ded8 (Metraipolis archive dc_d2e5b969ded8, sha256 bdeac72c77973506401a340ed330b8bed4451300cfcd784289662022607012e1)
BibTeX
@misc{dcd2e5b969ded8,
  title = {Celastrol increases anoikis sensitivity to suppress triple-negative breast cancer via EGFR pathway and p-EMT state regulation — Europe PMC PMID:41847133},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41847133},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d2e5b969ded8; sha256 bdeac72c77973506401a340ed330b8bed4451300cfcd784289662022607012e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41847133. Agents can read the archived copy with the MCP tool read_document.